Learn everything you need to know about successful options trading with this three-part video course. The following amendment has been made to the 'GSK publishes 2020 Dividend Dates' announcement released on 8 January 2020 at 15:11 under RNS No 1969Z.

As of 07 Oct 2020 no upcoming dividend payment date has been declared for a company with EPIC 'GSK' View keys dates for earnings releases, dividends and other company events. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View which stocks have been most impacted by COVID-19. GSK announces the following dividend dates for 2020. Glaxosmithkline Financial Calendar. GlaxoSmithKline employs 99,437 workers across the globe. {{ storiesRelated.scrollNewsPercent }}% Complete, Just Eat Takeaway delivers tasty rise in order growth, MJ Hudson acquires Ireland-based Bridge Group, London close: Stocks mixed as investors look to Europe summit, London midday: Stocks slip into the red as sterling steadies, GSK publishes provisional 2020 Dividend Dates, US close: Stocks finish lower as investors sift through earnings, Europe close: Stocks end on mixed note ahead of key EU leaders' summit, Thursday preview: EU summit, Schroders in the spotlight, Director dealings: Bigblu director makes share purchase via Harwood Capital, Broker tips: Hammerson, Diploma, Go-Ahead, Stagecoach, Touchstone upbeat after completing Chinook-1 well, FTSE 250 movers: Kainos surges; FirstGroup hit by downgrade, System1 reports 'marked reduction' in sales. The previous British American Tobacco Plc dividend was 52.6p and it went ex 3 months ago and it was paid 2 months ago. See what's happening in the market right now with MarketBeat's real-time news feed. Pre-Market earnings guidance on Wednesday, July, 29th.

In general, profits from business operations can be allocated to retained earnings or paid to shareholders in the form of dividends or stock buybacks. There are no upcoming events for GSK. Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. View GlaxoSmithKline's earnings history. Learn more. This represents a $1.97 annualized dividend and a yield of 4.88%. This payout ratio is at a healthy, sustainable level, below 75%. Export data to Excel for your own analysis. $0.4929.

GlaxoSmithKline has a market capitalization of $93.34 billion and generates $43.10 billion in revenue each year.

Twilio (NYSE: TWLO) Becomes A Darling Of Wall Street, Time to Ring the Register on The Container Store (NYSE: TCS) Stock, Buying Intuitive Surgical Makes Intuitive Sense, Sorrento Therapeutics (NASDAQ:SRNE) Quietly Moves Higher On COVID News, It’s Time To Buy Some Wells Fargo (NYSE:WFC), Buy the Post-Earnings Dip on Johnson & Johnson (NYSE: JNJ), GenMark Receives FDA Nod, Guides Revenue Higher—But Stock Gets Cheaper, 3 Reasons to Buy Chewy (NYSE:CHWY) Stock Now, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, 7 Gold Stocks to Buy Before the Fed Changes Its Mind, Receive Analysts' Upgrades and Downgrades Daily. View all competitors. GSK stock was purchased by a variety of institutional investors in the last quarter, including Avantax Advisory Services Inc., Regentatlantic Capital LLC, Minot Wealth Management LLC, Brookstone Capital Management, KG&L Capital Management LLC, Private Trust Co. NA, Centric Wealth Management, and Independence Bank of Kentucky.

The following amendment has been made to the 'GSK publishes 2020 Dividend Dates' announcement released on 8 January 2020 at 15:11 under RNS No 1969Z. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). announces the following dividend dates for 2020. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Learn about financial terms, types of investments, trading strategies and more. Obtains access to the information in a personal capacity; Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds; Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes. Dividend Summary. GlaxoSmithKline has a P/B Ratio of 3.96. © 2020 WebFG and Media Limited or its affiliated companies. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Q4 2020 Ex-dividend date amended to 18 February 2021.

Earnings for GlaxoSmithKline are expected to grow by 2.33% in the coming year, from $3.01 to $3.08 per share. There is not enough analysis data for GlaxoSmithKline. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. August 14, 2020.

October 8, 2020.

This represents a $1.97 annualized dividend and a dividend yield of 5.28%. GlaxoSmithKline plc . The next British American Tobacco Plc dividend went ex 11 days ago for 52.6p and will be paid in 1 month.

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. These dates are indicative and may be subject to change. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.

8 January 2020 This information is provided by RNS, the news service of the London Stock Exchange. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". All other details remain unchanged.

Do Not Sell My Information. GlaxoSmithKline has a PEG Ratio of 2.73. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. PEG Ratios above 1 indicate that a company could be overvalued. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock.

Terms and conditions relating to the use and distribution of this information may apply. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. ), GlaxoSmithKline has received 1,108 “underperform” votes. Top institutional investors include Envestnet Asset Management Inc. (0.04%), 10 15 Associates Inc. (0.01%), Farmers Trust Co. (0.01%), Ipswich Investment Management Co. Inc. (0.00%), Old Port Advisors (0.00%) and Avantax Advisory Services Inc. (0.00%). GSK Dividend Yield 5.16% GSK Annual Dividend $1.94 . RNS is approved by the Financial Conduct Authority to act … It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology; and strategic alliance with Merck KGaA to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein immunotherapy. All rights reserved. This information is provided by RNS, the news service of the London Stock Exchange. Fisker Inc (NYSE:SPAQ) Stock: The Next Big Player in EV? You may vote once every thirty days. This is a positive change from GlaxoSmithKline's previous quarterly dividend of $0.47. Receive a free world-class investing education from MarketBeat. The P/E ratio of GlaxoSmithKline is 11.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 19.76. View which stocks are hot on social media with MarketBeat's trending stocks report. View GlaxoSmithKline's Short Interest. GSK stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Chemung Canal Trust Co., 10 15 Associates Inc., Flagship Harbor Advisors LLC, Strategic Investment Advisors MI, Gofen & Glossberg LLC IL, Fulton Bank N. A., and Thomasville National Bank.

GSK announces the following dividend dates for 2020.